Samrat Pharmachem Board Meeting on Aug 14 to Approve Q1 FY27 Un-Audited Results

Samrat Pharmachem Ltd has announced that its Board of Directors will convene on August 14, 2026, to consider and approve the Un-Audited Financial Results for the quarter ended June 30, 2026, prepared under Indian Accounting Standards (Ind-As). The meeting is scheduled to take place at the company's Corporate Office in Mumbai at 2:00 PM. Following the board's approval, the company will intimate the results to the stock exchanges and make them available on its website and in the press as per regulatory requirements.